Ascentage Pharma Group International (AAPGV): Expected Profit

Ascentage Pharma - graphic logo of issuer AAPGV

Earnings expectations for Ascentage Pharma Group (AAPGV) reflect market sentiment, where the value of 0.03 expresses the metric level. Hematologists highly value the scientific contribution of Ascentage Pharma Group (AAPGV) to the development of targeted therapies. The brand is recognized as a global leader in the therapy of resistant leukemias through the blocking of apoptosis proteins. The strategy is based on the launch of innovative BCL-2 drugs for the US and Chinese markets.

AAPGV - Ascentage Expected Net Income over the range 01/25/2025 - 11/28/2025

Analytical breakdowns and data insights for company Ascentage (AAPGV)

- share price and consensus valuation forecast:
Fundamental company valuation:Ascentage, AAPGV
Brand item of Ascentage Pharma Group Ltd

Market expectations for Ascentage Pharma Group (AAPGV) often precede current financial results. The indicator is based on consensus net income per share forecasts, where expected marginal profit visualizes the trajectory of future returns. The upward trend of the line confirms fundamental stability, although peak values increase the risk of capital stagnation. The high authority of Ascentage Pharma Group in oncohematology converts scientific potential into analyst optimism, making this metric a key measure of the investment attractiveness of its therapeutic developments.

Competitors of Ascentage Pharma Group

Future Profit ONC|HALO: Expected Net Income|Future Profit RVMD (RevMed)|AAPG (Ascentage) - Expected Net Income|Projected Future Earnings CGON (cgoncology.com)|URGN - Future Profit|BCAX: Future Profit|PSNL - Projected Future Earnings|Erasca Corp (ERAS) - Expected Profit|Delcath - Expected Net Income|YMAB (Y-mAbs Therapeutics Inc) - Projected Future Earnings|Expected Net Profit Aura Biosciences, Inc. AURA|Projected Future Earnings CADL|Projected Future Earnings Accuray (ARAY)|Expected Profit SELLAS Life Sciences Group Inc. SLS|ACTU - Future Profit|CTOR: Future Profit|Expected Net Income HURA (TuHURA Biosciences Inc.)|TARA (Protara Therapeutics) - Future Profit|Expected Net Profit Fate Therapeutics Corp (FATE)|Future Profit WHWK|Net Profit Forecast TCRX (TScan Therapeutics, Inc.)|Projected Future Earnings CSBR|XBIT - Expected Net Profit|CEL-SCI Corporation - Future Profit|Expected Net Income OSTX|radiopharmtheranostics.com - Projected Future Earnings|ARTV: Expected Profit|ANL (adlainortye.com) - Future Profit|VERU - Company Profit Forecast|TPST (Tempest Therapeutics, Inc.) - Projected Future Earnings|Projected Future Earnings xiliotx.com|Expected Profit Enochian BioSciences (RENB)|Expected Profit MURA (Mural Oncology PLC)|Expected Profit Kairos Pharma Ltd KAPA|Projected Future Earnings OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - Projected Future Earnings|Company Profit Forecast Curis CRIS|APLM: Projected Future Earnings|Future Profit Tharimmune, Inc.|ADVB (Advanced Biomed) - Projected Future Earnings|Genprex - Forward Earnings|Expected Profit calidibio.com (CLDI)|SBFM (Sunshine Biopharma Inc.) - Expected Net Income|Projected Future Earnings XBIO (Xenetic Biosciences)|Salarius Pharmaceuticals (SLRX) - Expected Net Profit|PPBT: Future Profit|Expected Net Income AONC (American Oncology Network, Inc.)|BeOne Medicines (BGNE) - Expected Profit|Checkpoint Therapeutics, Inc (CKPT) - Projected Future Earnings|Expected Profit Elevation Oncology, Inc.|ICAD: Expected Net Income|Expected Profit ikenaoncology.com (IKNA)|Expected Profit NTBL (Notable Labs, Ltd.)|Projected Future Earnings VIRX (viracta.com)|MOR - Future Profit|NAYA - Expected Profit